The Archive · 2 posts
Innovating diagnostics! 🌟 Novacyt S.A. (NCYT) leads the way in infectious disease testing. Explore its cutting-edge solutions today. 🔬
Novacyt's first-half revenue rose 18% to around £11.6 million, although acquisition spending helped reduce cash to £8.9 million.
July 28, 2026
Showing 1 of 2 posts
Novacyt's earnings-accretive acquisition of Southern Cross Diagnostics boosts its APAC footprint and accelerates the group's path to breakeven.
JoshuaFebruary 23, 2026